Prevalence and Medium-Term Outcomes of Patients with Biopsy-Proven Intermediate- to High-Risk Prostate Adenocarcinoma with Low Intraprostatic Uptake on [68Ga]Ga-PSMA-11 PET/CT in the proPSMA Study

David C. Chen; James P. Buteau; Louise Emmett; Ramin Alipour; Felipe de Galiza Barbosa; Matthew J. Roberts; Aoife McVey; Jonathan O’Brien; Sidney Levy; Roslyn J. Francis; Nathan Lawrentschuk; Declan G. Murphy; Michael S. Hofman

doi:10.2967/jnumed.124.268901

Research ArticleClinical Investigation

Prevalence and Medium-Term Outcomes of Patients with Biopsy-Proven Intermediate- to High-Risk Prostate Adenocarcinoma with Low Intraprostatic Uptake on [⁶⁸Ga]Ga-PSMA-11 PET/CT in the proPSMA Study

David C. Chen, James P. Buteau, Louise Emmett, Ramin Alipour, Felipe de Galiza Barbosa, Matthew J. Roberts, Aoife McVey, Jonathan O’Brien, Sidney Levy, Roslyn J. Francis, Nathan Lawrentschuk, Declan G. Murphy and Michael S. Hofman

Journal of Nuclear Medicine March 2025, jnumed.124.268901; DOI: https://doi.org/10.2967/jnumed.124.268901

David C. Chen

1Molecular Imaging and Therapeutic Nuclear Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia;

2Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

James P. Buteau

1Molecular Imaging and Therapeutic Nuclear Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia;

3Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Louise Emmett

4Department of Theranostics and Nuclear Medicine, St. Vincent’s Hospital, Sydney, New South Wales, Australia;

5Garvan Institute of Medical Research, Sydney, New South Wales, Australia;

6St. Vincent’s Clinical School, University of New South Wales, Sydney, New South Wales, Australia;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ramin Alipour

1Molecular Imaging and Therapeutic Nuclear Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia;

3Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Felipe de Galiza Barbosa

7Department of Nuclear Medicine, University Hospital Zurich, Zurich, Switzerland;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Matthew J. Roberts

8Department of Urology, Royal Brisbane and Women’s Hospital, Herston, Queensland, Australia;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Aoife McVey

9Department of Radiology, University Hospital Geelong, Geelong, Victoria, Australia;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jonathan O’Brien

2Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Sidney Levy

1Molecular Imaging and Therapeutic Nuclear Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia;

3Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Roslyn J. Francis

10Department of Nuclear Medicine, Royal Brisbane and Women’s Hospital, Herston, Queensland, Australia;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Nathan Lawrentschuk

2Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia;

3Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia;

11Department of Urology, Royal Melbourne Hospital, Parkville, Victoria, Australia; and

12EJ Whitten Foundation Prostate Cancer Research Centre at Epworth, Richmond, Victoria, Australia

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Declan G. Murphy

2Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia;

3Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Michael S. Hofman

1Molecular Imaging and Therapeutic Nuclear Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia;

3Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Info & Metrics
PDF

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

SNMMI members

SNMMI Member Login

Individuals

Non-Member Login

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 66, Issue 4

April 1, 2025

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Complete Issue (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Prevalence and Medium-Term Outcomes of Patients with Biopsy-Proven Intermediate- to High-Risk Prostate Adenocarcinoma with Low Intraprostatic Uptake on [68Ga]Ga-PSMA-11 PET/CT in the proPSMA Study

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Prevalence and Medium-Term Outcomes of Patients with Biopsy-Proven Intermediate- to High-Risk Prostate Adenocarcinoma with Low Intraprostatic Uptake on [⁶⁸Ga]Ga-PSMA-11 PET/CT in the proPSMA Study

Journal of Nuclear Medicine Mar 2025, jnumed.124.268901; DOI: 10.2967/jnumed.124.268901

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Journal of Nuclear Medicine Mar 2025, jnumed.124.268901; DOI: 10.2967/jnumed.124.268901

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Info & Metrics
PDF

No related articles found.

PubMed
Google Scholar

Cited By...

No citing articles found.

Google Scholar

Keywords

prostate cancer
prostate-specific membrane antigen
PET/CT

Main menu

User menu

Search

Prevalence and Medium-Term Outcomes of Patients with Biopsy-Proven Intermediate- to High-Risk Prostate Adenocarcinoma with Low Intraprostatic Uptake on [⁶⁸Ga]Ga-PSMA-11 PET/CT in the proPSMA Study

Individuals

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Keywords